Our People
Professor Michael Leahy
Professor Michael Leahy is a clinical and laboratory haematologist trained in Haematology at Hammersmith Hospital (Royal Post Graduate Medical School) and The Royal Free Hospital London.
Professor Leahy has active role in Western Australian haematology and has furthered development of new molecular techniques for diagnosing and managing haematological disease, contributed to the development Patient Blood Management Programs in WA, improving patient outcomes and reducing blood product waste and costs.
He is also active in researching Immune response to COVID-19 vaccination in haematology patients. In addition to this he is the Network Director of East Metropolitan Health Service PathWest Laboratory Medicine and Clinical Professor at the Schools of Pharmacology and Medicine and Laboratory Medicine at the University of Western Australia.
In his role as Head of Department at Royal Perth Hospital he has been committed to Ensuring all patients have an opportunity to access new and novel therapies through joining Clinical Trials.
Dr Peter Tan
Dr Peter Tan is a consultant haematologist with a particular interest in research, and acute malignancies such as acute myeloid leukaemia (AML).
Dr Tan did his advanced training in Melbourne and Sydney and is Principle Investigator on numerous clinical trials and Co Investigator for trials run by the Australasian Leukaemia and Lymphoma Group.
In addition to his clinical work in both the public and private sectors and teaching commitments, he has won multiple awards both here and overseas for his work and is regularly invited to speak at conferences and is author on many papers in the fields of AML and myelodysplastic syndromes.
Dr Tony Calogero
Dr Tony Calogero is a consultant haematologist practicing at Royal Perth and Midland Hospitals.
Following his training at the University of Western Australia he was part of an Alfred Hospital/ Monash University Myeloma research group.
His roles as Clinical Lead of Haematology for the WA Cancer and Palliative Care Network and (WACPCN) Director of Haematology for WA Country Health Service (WACHS) reflect his interest in ensuring equity of access to cancer care and provision of haematology/ Oncology care to rural and remote patients.
Dr Ben Carnley
Dr Ben Carnley specialises in adult haematology with interest areas in myelodysplasia, multiple myeloma and lymphoma and is responsible for multiple clinical trials studying paroxysmal nocturnal hemoglobinuria at Royal Perth Hospital. He has worked both overseas and throughout regional areas of Western Australia.
Dr Carnley has been directly involved in the development of scientific research protocols and has spearheaded multiple quality assurance projects at our site.
Dr Carnley is the Director of Cell and Tissue Therapies WA who in conjunction with RPH provide specialist stem cell treatment for patients throughout the state.
Dr Hun Chuah
Dr Chuah is a clinician-scientist haematologist who is completing his PhD. His expertise is in liquid biopsy in acute myeloid leukaemia, myelodysplastic syndrome and myeloproliferative neoplasm. He specialises in translational research that overcomes important clinical challenges using laboratory innovations, to improve the outcome for patients suffering from haematological malignancies.
Throughout his PhD, Dr Chuah has been actively involved in method development in the genomic analysis of blood cancers, and developing ultra-sensitive genomic tools to detect variants at low limits of detection. He is also an integral member of the University of Western Australia research team that achieved the WA cytogenomic invention.
In clinical research, Dr Chuah is the principle investigator and associate investigator for a range of clinical trials at Royal Perth Hospital. These include trials evaluating role of novel therapies across a range of haematological malignancies, including myeloid, lymphoma and myeloma.
Associate Professor Agnes Yong
Associate Professor Agnes Yong trained in Medicine at the Queen’s University of Belfast, UK. Following advanced training in Clinical and Laboratory Haematology, and blood and marrow transplantation in London at the Hammersmith Hospital, she embarked on research on chronic myeloid leukaemia and obtained her PhD from Imperial College, University of London.
After post-doctoral research at the National Institutes of Health in Bethesda, Maryland, USA, she moved to Australia in 2010 consulting at the Royal Adelaide Hospital before moving to Perth in 2019. She has interests in chronic myeloid leukaemia, haematopoietic stem cell transplantation and survivorship.
As well as interests in clinical research in myeloma, leukaemia and lymphoma, she enjoys teaching and mentoring, and is a recipient of the Professor Derek Frewin AO citation for excellence in clinical teaching.
Assoc. Prof Yong has multiple publications in chronic myeloid leukaemia and transplantation, and is Associate Editor of the British Journal of Haematology and Frontiers in immunology.
Dr John Balendra
Dr John Balendra is a Haematology Fellow at Royal Perth Hospital. He completed his undergraduate medical degree at Monash University before completing specialist haematology training in Western Australia.
He holds appointments as an Adjunct Clinical lecturer at the University of Western Australia and Senior Clinical Lecturer at the Rural Clinical School of WA.
He is currently undertaking his own research in patient outcomes following chemo-radiotherapy as well as serving as a Sub Investigator on multiple clinical trials.
Dr Annalise Martin
Dr Annalise Martin is a Haematology Fellow with an extensive background in haematology and microbiology.
She is heavily involved in research, having an extensive list of publications that she has appeared as an author.
Dr Martin has received numerous awards for her research both within Australia and overseas and her work has been presented at conferences worldwide.
She enjoys taking an active mentoring role and has supervised many PhD students. Her work has been used in press and radio releases.